Adarotene
Alternative Names: ST 1926Latest Information Update: 04 Nov 2017
At a glance
- Originator sigma-tau SpA
- Class Antineoplastics; Retinoids
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Solid-tumours in Italy
- 05 Mar 2007 Phase-I clinical trials in Solid tumours in Italy (unspecified route)
- 11 Dec 2006 Data presented at the 18th EORTC-NCI-ACCI Symposium on Molecular Targets and Cancer Therapeutics (EORTC-NCI-ACCI 2006) added to the Cancer pharmacodynamics section